IAPB General Assembly registration deadline

Article

The International Agency for the Prevention of Blindness (IAPB) has announced that the closing date for the early-bird registration and abstract submission for the 9th General Assembly is 31 March 2012.

The International Agency for the Prevention of Blindness (IAPB) has announced that the closing date for the early-bird registration and abstract submission for the 9th General Assembly is 31 March 2012.

This year's General Assembly will focus on "Eye Health: Everyone's Business" and will be held in the HICC, Hyderabad, India, between 17-20 September. The event will provide the opportunity for ophthalmologists, optometrists, hospitals, public health policy-makers and industry experts to discuss the topics of blindness prevention and visual impairment.

The IAPB General Assembly will play host to over 150 guest speakers, 30 courses and lectures, rapid-fire rounds, 200 posters and 45 oral presentations. The best poster and oral presentation will each receive a prize.

Professor Hugh R. Taylor, the 9GA Programme Committee Chair, said, "The assembly is a must for anyone interested in better service delivery. Whether in a single clinic, as part of a district health programme or to a whole country."

All registrations completed before the deadline will automatically enter an iPad 2 prize draw. To register or submit an abstract please visit http://www.9ga.iapb.org

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.